Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) |
---|---|
6/30/2025 | $ -38.54M |
3/31/2025 | $ -42.19M |
12/31/2024 | $ -39.83M |
9/30/2024 | $ -34M |
6/30/2024 | $ -28.43M |
3/31/2024 | $ -29.08M |
12/31/2023 | $ -28.45M |
9/30/2023 | $ -32.2M |
6/30/2023 | $ -35.07M |
3/31/2023 | $ -33.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Dec 31, 2020
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | $ -402.08M |
max | $ 443M |
average | $ 28.81M |
median | $ 1.05M |
std | $ 130.86M |